These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28442121)

  • 21. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.
    Ho SB; Bräu N; Cheung R; Liu L; Sanchez C; Sklar M; Phelps TE; Marcus SG; Wasil MM; Tisi A; Huynh L; Robinson SK; Gifford AL; Asch SM; Groessl EJ
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2005-14.e1-3. PubMed ID: 25724704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
    Van den Eynde E; Crespo M; Esteban JI; Jardi R; Ribera E; Carbonell J; Rodríguez-Frias F; Falco V; Curran A; Imaz A; Villar del Saz S; Ocaña I; Esteban R; Pahissa A
    Clin Infect Dis; 2009 Apr; 48(8):1152-9. PubMed ID: 19275492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary study of two antiviral agents for hepatitis C genotype 1.
    Lok AS; Gardiner DF; Lawitz E; Martorell C; Everson GT; Ghalib R; Reindollar R; Rustgi V; McPhee F; Wind-Rotolo M; Persson A; Zhu K; Dimitrova DI; Eley T; Guo T; Grasela DM; Pasquinelli C
    N Engl J Med; 2012 Jan; 366(3):216-24. PubMed ID: 22256805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.
    Maier MM; Ross DB; Chartier M; Belperio PS; Backus LI
    Am J Public Health; 2016 Feb; 106(2):353-8. PubMed ID: 26562129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.
    Vermehren J; Yu ML; Monto A; Yao JD; Anderson C; Bertuzis R; Schneider G; Sarrazin C
    J Clin Virol; 2011 Oct; 52(2):133-7. PubMed ID: 21803650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.
    Durante-Mangoni E; Zampino R; Portella G; Adinolfi LE; Utili R; Ruggiero G
    Clin Infect Dis; 2009 Aug; 49(4):498-506. PubMed ID: 19591593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of treatment for chronic hepatitis C virus infection.
    Talwani R; Gilliam BL; Rizza SA; Nehra V; Temesgen Z
    Drugs Today (Barc); 2012 Mar; 48(3):219-31. PubMed ID: 22462041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
    Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C;
    N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of recurrent hepatitis C virus after liver transplantation.
    Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
    World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China.
    Wei L; Li J; Yang X; Wang G; Feng B; Hou J; Duan Z; Jia J; Ren H; Niu J; Chen X; Wang FS; Shang J; Bo Q; Li R; Liu Y; Zhuang H
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1995-2003. PubMed ID: 27043040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
    Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
    Perrillo RP; Gish R; Falck-Ytter YT
    Gastroenterology; 2015 Jan; 148(1):221-244.e3. PubMed ID: 25447852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic hepatitis C virus infection: clinical picture and treatment possibilities].
    Annicchiarico BE; Siciliano M; Gasbarrini A
    G Ital Nefrol; 2012; 29 Suppl 54():S103-8. PubMed ID: 22388839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American Gastroenterological Institute Guideline on the Management of Crohn's Disease After Surgical Resection: Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2017 Jan; 152(1):276. PubMed ID: 27987625
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of chronic hepatitis B and C virus infections in the clinical practice].
    Panther E; Thimme R
    Praxis (Bern 1994); 2012 Jan; 101(1):37-42. PubMed ID: 22219073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
    Charlton M; Everson GT; Flamm SL; Kumar P; Landis C; Brown RS; Fried MW; Terrault NA; O'Leary JG; Vargas HE; Kuo A; Schiff E; Sulkowski MS; Gilroy R; Watt KD; Brown K; Kwo P; Pungpapong S; Korenblat KM; Muir AJ; Teperman L; Fontana RJ; Denning J; Arterburn S; Dvory-Sobol H; Brandt-Sarif T; Pang PS; McHutchison JG; Reddy KR; Afdhal N;
    Gastroenterology; 2015 Sep; 149(3):649-59. PubMed ID: 25985734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--a clinical overview.
    Shah M; Younossi ZM; Opsha Y
    Am J Manag Care; 2015 Mar; 21(5 Suppl):S76-85. PubMed ID: 26167957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.